Cushman & Wakefield
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 weeks.
- Recent price momentum is -14.5% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 6.5% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-21 20:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation B
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 42.0x | Better than 12% |
| Forward P/E | 9.3x | Better than 84% |
| Price / Sales | 0.3x | Better than 96% |
| P/E vs own 5-yr range | 82nd pctl | Better than 24% |
Growth D
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 0.6% | Better than 30% |
| Net income CAGR (3Y) | -23.4% | Better than 15% |
| Free cash flow CAGR (3Y) | -30.4% | Better than 11% |
Profitability C
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 18.3% | Better than 15% |
| Operating margin | 4.5% | Better than 33% |
| Net margin | 0.9% | Better than 28% |
| Return on equity | 4.8% | Better than 36% |
| Return on invested capital | 5.1% | Better than 45% |
Momentum C
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -15.0% | Better than 39% |
| 6-month return | -2.3% | Better than 52% |
| 12-month return (ex latest month) | -24.4% | Better than 12% |
| Distance below 52-week high | 27.6% | Better than 46% |
Financial Health C
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.1x | Better than 25% |
| Debt to assets | 39.0% | Better than 28% |
| Interest coverage | 1.5x | Better than 32% |
| Free cash flow / net income | 332.2% | Better than 87% |
Analyst View C
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 50.0% | Better than 26% |
| Upside to average target | 29.7% | Better than 49% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 12.89
- Open
- 12.95
- Day range
- 12.52 - 13.30
- Avg price
- 12.70
- Volume
- 3.21M
- Turnover
- 40.79M
- Turnover ratei
- 1.38%
- Volume ratioi
- 1.48
- Amplitudei
- 6.05%
- 52-week rangei
- 10.88 - 17.40
Valuation
- P/Ei
- 33.13
- P/E (TTM)i
- 41.97
- P/Bi
- 1.41
- EPSi
- 0.38
- Book value / shi
- 8.94
- Net profit
- 89.21M
- Net assets
- 2.10B
Share structure
- Market cap
- 2.96B
- Float capi
- 2.93B
- Shares out
- 234.76M
- Float sharesi
- 232.73M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2018-08-02
27.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-7.87M net over the window
Short interest
- Shares short
- 15.37M
- % of floati
- 6.55%
- Days to coveri
- 4.93
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Cushman & Wakefield (CWK)?
Cushman & Wakefield last traded at 12.59. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Cushman & Wakefield's market cap?
About 2.96B.
What is the P/E ratio of Cushman & Wakefield?
The trailing twelve-month P/E is 41.97, above its own 5-year average of 28.35 — toward the top of its historical range (81.58% percentile). See the Valuation tab for the full history.
Does Cushman & Wakefield pay a dividend?
Cushman & Wakefield does not currently pay a regular dividend.
Is Cushman & Wakefield a buy according to analysts?
The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 16.33, which implies 29.7% upside from the current price. This is not investment advice.
What is Cushman & Wakefield's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Cushman & Wakefield a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Cushman & Wakefield discussion 0 comments